Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Combination Antivirals vs Oseltamivir for Influenza
NCT01227967Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Sep 2010
- Primary completion
- May 2016
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 5
01
Overview
Phase 2, randomised, double-blind trial of amantadine and ribavirin in influenza (2 arms), sponsored by National Institute of Allergy and Infectious Diseases. Primary endpoint: Percentage of Participants With Virus Detectable by Quantitative PCR (qPCR) in Nasopharyngeal (NP) Swabs at Day 3. Started Sep 2010; status: completed.
02
Drugs
amantadineribavirin
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01227967.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01227967.